TNF and Alzheimer disease: Although the use of inflammatory mediators as peripheral AD biomarkers has not been established, we found abnormalities in peripheral levels of both Aβ and TNF-α in T2DM monkeys, so we hypothesized that a combination of Aβ and TNF-α might more accurately identify T2DM monkeys in a preclinical AD state.